Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1999-4-26
pubmed:abstractText
Interleukin-1 receptor antagonist (IL-1ra) is a naturally occurring cytokine whose only known function is the inhibition of interleukin-1 (IL-1). Using a reverse genetic approach in mice, we previously showed that increasing IL-1ra gene dosage leads to reduced survival of a primary listerial infection. In this study, we characterize further the role of endogenously produced IL-1ra and, by inference, IL-1 in murine listeriosis. IL-1ra overexpression inhibits, but does not eliminate, primary immune responses, reducing survival and increasing bacterial loads in the target organs. We demonstrate that IL-1ra functions in the innate immune response to regulate the peak leukocyte levels in the blood, the accumulation of leukocytes at sites of infection, and the activation of macrophages during a primary infection. Reduced macrophage class II major histocompatibility complex expression was observed despite increased gamma interferon (IFN-gamma) levels, suggesting that IL-1 activity is essential along with IFN-gamma for macrophage activation in vivo. We also show that IL-1ra plays a more limited role during secondary listeriosis, blunting the strength of the delayed-type hypersensitivity response to listerial antigen while not significantly altering cellular immunity to a second infectious challenge. When these results are compared to those for other mutant mice, IL-1ra appears to be unique among the cytokines studied to date in its regulation of leukocyte migration during primary listeriosis.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-1531270, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-1531668, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-1826128, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-1828262, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-2448381, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-3468120, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-7594594, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-7621071, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-7768607, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-7775431, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-8051414, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-8097322, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-8476559, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-8501395, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-8543820, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-8630372, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-8794012, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-8855299, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-8910794, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-9036973, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-9039774, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-9164949, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-9278338, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-9314071, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-9314076, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-9314078, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-9317135, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-9324362, http://linkedlifedata.com/resource/pubmed/commentcorrection/10085034-9778220
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0019-9567
pubmed:author
pubmed:issnType
Print
pubmed:volume
67
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1901-9
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:10085034-Animals, pubmed-meshheading:10085034-Antigens, Bacterial, pubmed-meshheading:10085034-Cell Movement, pubmed-meshheading:10085034-Gene Expression, pubmed-meshheading:10085034-Hypersensitivity, Delayed, pubmed-meshheading:10085034-Interferon-gamma, pubmed-meshheading:10085034-Interleukin 1 Receptor Antagonist Protein, pubmed-meshheading:10085034-Leukocytes, pubmed-meshheading:10085034-Leukocytosis, pubmed-meshheading:10085034-Listeria monocytogenes, pubmed-meshheading:10085034-Listeriosis, pubmed-meshheading:10085034-Liver, pubmed-meshheading:10085034-Macrophage Activation, pubmed-meshheading:10085034-Mice, pubmed-meshheading:10085034-Mice, Inbred C57BL, pubmed-meshheading:10085034-Mice, Inbred CBA, pubmed-meshheading:10085034-Mice, Transgenic, pubmed-meshheading:10085034-Peritoneum, pubmed-meshheading:10085034-Receptors, Interleukin-1, pubmed-meshheading:10085034-Sialoglycoproteins
pubmed:year
1999
pubmed:articleTitle
Effects of interleukin-1 receptor antagonist overexpression on infection by Listeria monocytogenes.
pubmed:affiliation
Department of Biochemistry and Molecular Biophysics, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.